Neurosarcoidosis: Evolving Diagnostic and Management Strategies*
Time: 12:00 PM to 1:00 PM
Description
Improved methods have evolved for the diagnosis and treatment of neurosarcoidosis. Imaging characteristics help clinicians by pointing to the diagnosis of neurosarcoidosis based on more specific MRI findings in the brain and spinal cord. Spinal fluid analysis findings are nonspecific but research delving into biomarker panels in neurosarcoidosis are evolving. Biopsy proof remains important. Treatment options have expanded away from the use of corticosteroids alone avoiding the side effects of steroid excess. Ideas of projecting prognosis and identifying patients needing more aggressive therapy at diagnosis are evolving.
Objectives
Apply updated consensus statements and imaging and laboratory biomarkers in diagnosing neurosarcoidosis.
Distinguish neurosarcoidosis and the many mimics that can hinder diagnosis.
Apply new strategies for treatment to manage patients with neurosarcoidosis.
Speakers
Diagnosis and Evolving Philosophies of Care for Patients with Neurosarcoidosis
DescriptionThis presentation will discuss diagnostic criteria for neurosarcoidosis and current strategies to treat patients with neurosarcoidosis.
SpeakersMimics and Approaches in Neurosarcoidosis Myelitis
DescriptionNeurosarcoidosis myelitis is a rare but disabling condition that requires prompt diagnosis and treatment to halt inflammation and disease progression. This session will review key clinical and imaging characteristics to distinguish neurosarcoidosis myelitis from among its mimickers and discuss approaches to diagnostic conundrums and management.
SpeakersUpdates in our Understanding of Biomarkers and Laboratory Findings in Neurosarcoidosis
DescriptionIn this session there will be an update about new approaches to evaluate neurosarcoidosis and use of disease biomarkers to characterize phenotypes and outcomes.